Author:
RАKISHEVА ZH. K., ,BАLАSАNYANTS G. S.,АKISHEVА А. S.,TSEPKE А. B.,SOLOVIEVА N. S., , , ,
Reference13 articles.
1. Al-Mutairi N.M., Ahmad S., Mokaddas E. Molecular screening versus phenotypic susceptibility testing of multidrug-resistant mycobacterium tuberculosis Isolates for streptomycin and ethambutol. Microb. Drug. Resist., 2018, Jan. 16. https://doi.org/10.1089/mdr.2017.0294
2. Asaad A.M., Alqahtani J.M. Primary anti-tuberculous drugs resistance of pulmonary tuberculosis in southwestern Saudi Arabia. J. Infect. Public Health, 2012, vol. 5, no. 4, pp. 281-285.
3. Cambau E., Viveiros M., Machado D., Raskine L., Ritter C., Tortoli E., Matthys V., Hoffner S., Richter E., Del Molino M.P., Cirillo D.M. Revisiting susceptibility testing in MDR-TB by a standardized quantitative phenotypic assessment in a European multicentre study. J. Antimicrob. Chemother., 2015, vol. 70, no. 3, pp. 686-696.
4. Kim H.W., Kim J.S. Treatment of latent tuberculosis infection and its clinical efficacy. Tuberc. Respir. Dis. (Seoul), 2018, vol. 81, no. 1, pp. 6-12.
5. Kuo C.Y., Wang W.H., Huang C.H., Chen Y.H., Lu P.L. Resistance to first- and second-line antituberculosis drugs in Southern Taiwan: Implications for empirical treatment. J. Microbiol. Immunol. Infect., 2017, vol. 17, pp. S1684-S1182.